Skip to content

Cancer Detection in Pancreatic Cysts

Pancreatic Cyst DNA Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00222898
Enrollment
300
Registered
2005-09-22
Start date
2004-06-30
Completion date
Unknown
Last updated
2007-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cyst, Pancreatic Neoplasm, Pancreatic Pseudocyst

Keywords

Pancreatic Cyst, PANDA Study

Brief summary

The purpose of this study is to assist with early and accurate diagnosis of cancer in pancreatic cysts based on the analysis of DNA obtained by endoscopic ultrasound guided fine needle aspiration

Detailed description

The study of pancreatic diseases is hindered by the organ's deep seated location and especially lack of symptoms during the early stages of disease development and progression e.g. pancreatic cancer. This is particularly true of pancreatic cysts, the variety and the malignant potential of which encompass a broad spectrum. The radiological features distinguishing a benign from a pre-malignant to a frankly malignant cyst in the pancreas are frequently underwhelming and have lead to the clinical practice of sampling all but the most obvious. The yield of the aspirate in turn is frequently not of a quality upon which a clinical decision can be based. Most would agree that the best approach for management of pancreatic cystic neoplasm lies in early diagnosis, ideally at a precancerous stage. The effectiveness and applicability of this study is the based on the ability of the cyst DNA analysis to stratify the patients at risk of developing pancreatic cancer based on the extent of accumulated mutational damage.

Interventions

PROCEDUREDNA analysis of pancreatic cyst fluid / buccal swab

Sponsors

VA Pittsburgh Healthcare System
CollaboratorFED
American Society for Gastrointestinal Endoscopy
CollaboratorOTHER
University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Previously scheduled for Endoscopic ULtrasound for evaluation of pancreatic cyst

Exclusion criteria

* Any condition that would preclude safe performance of EUS/FNA

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026